Objective: The purpose of this study was to explore the plausible mechanism of type 2 diabetes patients' cognitive impairment by analyzing the levels of serum amyloid β-protein (Aβl-42), adiponectin and CRP.
Introduction
Diabetes mellitus (DM) remains a global epidemic, with an estimated 400 million people affected by diabetes worldwide [1] . With the increase of people's living standards and living pressure, diabetes has become a major threat to young people. There are two major types of DM, including insulin-dependent diabetes (type 1 DM
[T1DM]) and insulin-independent diabetes (type 2 DM [T2DM]). Approximately, 90% of people with diabetes have T2DM. The main damage of diabetics is long-term poor glycemic control, which leads to complications, including kidney disease, hypertension, infection, diabetic foot, etc. [2] . Furthermore, diabetes patients are often associated with cognitive impairment, decreased learning and memory ability, reduced understanding and judging ability, and even dementia [3] . The dementia risk for type 2 diabetes patients is about 1.5 to 2.0 times higher than the normal population. DM possesses a bidirectional relationship with major depressive disorder (MDD) [4] . MDD has significant effects on the course and outcome of diabetes [5] . Some studies revealed MDD has a specific association with T2DM [6] . Likewise, elevated depressive symptoms have been associated with a higher risk of developing T2DM [7] . However, connection of these two conditions is poorly characterized. Diabetes is closely associated with cognitive impairment and the mechanism is complicated. A series of pathological changes resulted from glycometabolic disorder or insulin resistance can cause hippocampus and other memory, study-related tissues and organs damaging, then causing cognitive impairment. This study provided the evidence-based medicine for related mechanism and early cognitive impairment screening by analyzing the connection between type 2 diabetes patients cognition and serum amyloid β-protein-42 (Aβl-42) levels.
Materials and Methods

Sample source
84 patients diagnosed with type 2 diabetes in the Department of Endocrinology, Xiangyang Central Hospital from January to December 2014 were selected as the case group, including 50 males and 34 females (aged from 25 to 75 years old). The selected patients were tested twice for fasting blood glucose (GLU), which conforms to 2013 China type 2 diabetes guidelines diagnostic criteria. The healthy subjects in medical examination center were chosen as the control group, including 40 males and 20 females, aged from 28 to 72 years old. The control group had no history of diabetes and family history of diabetes after investigation, and their blood glucose was between 3.9 and 6.1 mmol/L.
Exclusion criteria of two groups
The following is exclusion criteria: (1) association with acute complication of diabetes; (2) congenital mental retardation, multiple occurrences of cerebral stroke or insane person, epilepsy; (3) anti-depression drugs or immunosuppressants users; (4) severe liver and kidney dysfunction; (5) 2 years with alcohol dependence or drug abuse and dependence; (6) history of malignancy, infected patients; (7) refused to be in the group or did not fit the Scale testers.
Clinical data collection
Data in these two groups were collected, including gender, age, years of education, body mass index (BMI), recording fasting glucose, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), glycosylated hemoglobin (HbA1C).
The repeatable battery for the assessment of neuropsychological status (RBANS) scale
Trained physician used RBANS scale to evaluate the cognitive function of patients. Patients completed subtest in 30-40 min, including immediate memory (memory studying, story retelling), visual span (graphic copying, positioning line), speech functions (pattern naming, semantic fluency), attention (digit span, coding test), delay memory (vocabulary memory, vocabulary recognition, story recall, graphic recall), etc. Scale scores were converted based on different ages of subjects, and then converted to standard scores.
Self-rating depression scale (SDS)
Trained physician performed the Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS) tests.
The SDS and SAS were set up by Zung in 1971. A total of 20 items and four-grade score were used, wherein forward scoring and reverse scoring occupied half, respectively. The questionnaires were simple and easy to evaluate the depression and anxiety degree of patients. ≥ 50 percentage of patients were complicated with depression or anxiety, <50 percentage of patients were not complicated with depression or anxiety.
2.6 Serum Aβl-42, adiponectin and C-reactive protein (CRP) level assay 5 ml of fasting blood from two groups of patients were collected and centrifuged for 10 min. The serum was collected and stored at -80°C. The serum Aβl-42 and adiponectin levels were individually determined by ELISA (Jingmei bio-company). C-reactive protein was detected by Siemens BNP II specific protein analyzer.
Statistical methods
SPSS 20.0 software was used for statistical analysis, normal distributed measurement data was expressed as (x ± s), t test was conducted for comparison between groups; non-normal distributed measurement data was expressed as M
Results
Comparison of clinical data in two groups
Gender, age, years of education and TC, LDL-C levels of the two groups were compared and there is no significant difference. The levels of BMI, GLU and HbA1C in the case group were significantly higher than control group (p<0.05) ( Table 1) . 
Group
The comparison of RBANS scale score and serum Aβl-42 levels in two groups
Immediate memory, visual span, speech function, attention and delay memory scores of RBANS scale and standard scores in the case group were lower than the control group, the difference was statistically significant (p<0. 05) ( Table 1) . Aβl-42 levels in the case group were higher than the control group, the difference was statistically significant (p<0.05) ( Table 2) . The results of this study showed that the RBANS scale subtest scores and standard scores of the case group are lower than the control group, suggesting that type 2 diabetic patients have cognitive impairment. Table 3 Adipose tissue is an active endocrine organ. Adiponectin is one of adipokines from adipose tissue, which exerts biological effects mainly by combining with its acceptors Adipo R1 and Adipo R2. These two acceptors are expressed in skeletal muscle, liver, pituitary and brain endothelial cells [12] . Adiponectin is associated with variety of diseases including diabetes, obesity, abnormal lipid metabolism, hypertension and other cardiovascular disease,
Group
i.e. neurodegenerative diseases. Adiponectin function as endocrine hormones and can improve insulin sensitivity, improve insulin resistance, anti-intimal hyperplasia, improve lipid metabolism, anti-hyperglycemia, antiinflammatory, anti-atherosclerosis. Insulin is a neurotrophic factor. A long time serious shortage of insulin can cause neuron degeneration. Craft and others find that daily intranasal insulin therapy can improve mild cognitive impairment which forgetfulness is the main symptom [13] . At the same time, these results show that the memory function is changed with the Aβl-42 level and the altered ratio of tau protein and Aβl-42. Table 2 shows T2DM serum adiponectin levels are significantly lower than the control group, but A42 levels are in contrast. Table 3 shows that adiponectin levels are positively correlated with RBANS scale subtest scores and standard scores [14] , indicating that adiponectin and Aβl-42 are risk factors causing cognitive impairment. Adiponectin also adjusts mood state, anti-depression, enhances memory and improves cognitive function and other beneficial effects [15] . Related CRP is a typical acute phase protein synthesized in the liver. In patients with tissue injury or infection, there will be a sharp rise in the CRP levels in the body. CRP as a sensitive marker of inflammation has been involved in a variety of human development of inflammation. Studies have shown that the abnormal high CRP expression can be detected in senile plaques and neurofibrillary tangles of Alzheimer patients. The abnormal high expression levels of inflammatory cytokines in elderly patients with T2DM may be through the following mechanisms eventually leading to cognitive dysfunction: significantly higher levels of inflammatory factors may prompt the Tau protein phosphorylation and be associated with fibrous Ab deposition and undernourished neurite formation [17] [18] .
In short, Type 2 diabetes patients could lead to cognitive impairment, and the process of its occurrence is associated with Aβl-42 serum levels remaining higher for a long time, adiponectin reduction and elevated CRP levels induced by inflammation factors. Adiponectin can lead to cognitive impairment by Aβl-42 deposition occurrence and aggravation, resulting in learning, living ability decreasing, severe cases can be developed to dementia. Therefore, it is recommended that patients newly diagnosed with type 2 diabetes should be monitored regularly, and makes the necessary intervention to delay the occurrence of cognitive impairment to improve the quality of life of diabetes patients.
T2DM significantly impairs the cognitive function in elderly patients. The impact of DM metabolism on cognitive functions in elderly patients should be taken seriously. Starting from prevention to reduce the prevalence of Alzheimer and delay its course effectively. In conclusion, Type 2 diabetes patients suffer from cognitive impairment and the mechanism may be associated with increased serum Aβl-42, and decreased adiponectin and inflammation reaction. Detection of serum Aβl-42 and adiponectin could be used as an indicator for the degree of cognitive impairment in Type 2 diabetes patients.
